Calyxt, Inc. Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information (Tables)

3 Months Ended

Mar. 31, 2022

Certain statement of operations amounts are as follows:


	Three Months Ended March 31,
In Thousands	2022		2021
Stock-based compensation expense:
Research and development	$	30	$	392
Selling, general, and administrative		501		(1,842	)

Total	$	531	$	(1,450	)


	Three Months Ended March 31,
In Thousands	2022			2021
Interest, net:
Interest expense	$	(10	)	$	(360	)
Interest income		1			14
Common stock warrants - financing costs amortization		(8	)		—

Total	$	(17	)	$	(346	)

Certain balance sheet amounts are as follows:


In Thousands	As of March 31, 2022		As of December 31, 2021
Cash, cash equivalents, and restricted cash:
Cash and cash equivalents	$	17,285	$	13,823
Restricted cash		499		499
Non-current restricted cash		99		99

Total	$	17,883	$	14,421

Supplemental statement of cash flows information is as follows:

Non-cash

transactions not reported in the consolidated statement of cash flows is as follows:


	As of March 31,
In Thousands	2022			2021
Receivable from Jefferies for shares issued under ATM facility	$	(260	)	$	—
Non-cash additions to land, buildings, and equipment	$	(202	)	$	—
Unpaid stock offering costs included in stockholders’ equity	$	257		$	—
Cumulative effect of adoption of lease accounting standard on stockholders’ equity	$	832		$	—
Establishment of operating lease right-of-use assets and associated operating lease liabilities	$	14,090		$	—